Evaluation of the clinical utility of urocortin 1 in systolic heart failure

Yildirim E., Keles I., Cakmak H. A., Cosansu K., Can G., Ikitimur B.

KARDIOLOGIA POLSKA, cilt.72, sa.5, ss.452-458, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 72 Sayı: 5
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5603/kp.a2013.0353
  • Dergi Adı: KARDIOLOGIA POLSKA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.452-458
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Urocortin 1 (UCN1) has cardiostimulatory, vasodilatory, diuretic and natriuretic effects, and its expression increases in heart failure (HF). Aim: To determine UCN1 levels in patients with HF, to evaluate UCN1's relationship with various clinical parameters, and to assess UCN1 as a diagnostic marker in HF, compared to pro-B-type natriuretic peptide (pro-BNP).